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Abstract 
Novel treatments are needed to prevent candidiasis/candidemia infection due to 
the emergence of Candida species resistant to current antifungals. Considering the 
yeast-to-hyphae switch is a critical factor to Candida albicans virulence, phenols 
common in plant sources have been reported to demonstrating their ability to pre-
vent dimorphism. Therefore, phenols present in many agricultural waste stress (fe-
rulic (FA) and gallic (GA) acid) were initially screened in isolation for their yeast-to-
hyphae inhibitory properties at times 3, 6, and 24 hr. Both FA and GA inhibited 50% 
of hyphae formation inhibitory concentration (IC50) but at a concentration of 8.0 
± 0.09 and 90.6 ± 1.05 mM, respectively, at 24 hr. However, the inhibitory effect of 
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FA increased by 1.9–2.6 fold when combined with different GA concentrations. GA 
and FA values decreased even lower when sinapic acid (SA) was added as a third 
component. As evidenced by concave isobolograms and combination indexes less 
than 1, both GA:F A and GA:FA:SA combinations acted synergistically to inhibit 50% 
hyphae formation at 24 hr. Lastly, acetylation of histone H3 lysine 56 acetylation 
(H3K56) was higher in response to the triple phenolic cocktail (using the IC50 24 hr 
inhibitory concentration level) comparable with the nontreated samples, indicating 
that the phenols inhibited hyphal growth in part by targeting H3K56 acetylation. 
Keywords — acetylation, Candida albicans, N-acetylglucosamine, phenols, syner-
gism, yeast-to-hyphae transition  
1   Introduction 
Candida albicans inhabits the human gastrointestinal, oral, and vaginal 
mucosa as a dormant commensal member but can become an oppor-
tunistic pathogen when its environment is compromised. The patho-
genicity of C. albicans has been linked to its ability to switch from a 
yeast-to-hyphae phenotype (Sudbery, Gow, & Berman, 2004) as the 
latter filamentous form facilitates penetration of the epithelial tissue 
followed by colonization to other body organs (Phan, Myers, Fu, et 
al., 2007). Candida infections of the mucosal membranes (candidia-
sis) or the bloodstream (candidemia; Miceli, Díaz, & Lee, 2011) have 
led to mortality rates of 30–40% in critically ill individuals (immuno-
deficiency syndrome, hematological malignancy) (Kullberg & Aren-
drup, 2015). In fact, C. albicans has become the most common cause 
of nosocomial bloodstream infection in hospitalized patients (Magill, 
Edwards, Bamberg, et al., 2014). 
However, anticandidal agents are critically limited, with only the 
azoles and polyenes providing the most effective protection (Sardi, 
Almeida, & Mendes Giannini, 2011; Sudbery et al., 2004). With the in-
creased use of these two types of antifungal agents, Candida species 
resistant to azoles and polyenes is also increasing (Lortholary et al., 
2011; Zida, Bamba, Yacouba, Ouedraogo-Traore, & Guiguemdé, 2017). 
For example, fluconazole resistant C. albicans has recently been de-
clared a “serious threat” by the US Centers for Disease Control and 
Prevention (CDC, 2013).  
Development of antifungals that act on virulence factor rather than 
killing the benign organism is gaining interest (Shareck & Belhumeur, 
2011). This treatment strategy is especially significant when a microbe 
is a natural member of the human microbiome, such as C. albicans, as 
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killing the nonpathogenic members may result in colonialization of a 
more lethal organisms. Another complementary strategy for protect-
ing against infectious organisms also garnering more attention is the 
use of a cocktail of antifungals that preferably act as synergists (Lewis 
& Kontoyiannis, 2001). Thus, the antifungal activity is expected to be 
greater than the individual contribution of each compound, and a po-
tential benefit is the reduction of C. albicans resistance to these syn-
ergistic agents. 
Plant based phenols have been shown to induce multiple health 
benefits, including protecting against human infectious diseases (Faria 
et al., 2011; Gallucci et al., 2014). These compounds are ubiquitously 
distributed in the plant kingdom and, as secondary metabolites, pro-
tect the plant against several environmental stressors (Manach, Scal-
bert, Morand, Rémésy, & Jiménez, 2004). The potential antifungals 
have been primarily studied based on their ability to inhibit cellular 
growth (Faria et al., 2011; Guzman, 2014; Kanwal, Hussain, Latif Sid-
diqui, & Javaid, 2010). Isolated phenols are also typically used for 
these purposes despite emerging evidence that show whole food sys-
tems or phenolic-rich extracts impart greater benefits than the sum of 
the individual components (synergism) (Junio, Sy-Cordero, Ettefagh, 
et al., 2011). 
Yet, a critical lack of knowledge remains on the ability of phenolic 
synergists to prevent the C. albicans hyphae phenotypes, with nota-
ble exceptions (Canonico et al., 2014; Kazuko, Sato, & Azuma, 2010; 
Saito, Tamura, Imai, Ishigami, & Ochiai, 2013). However, the referenced 
research does not account for responsible components or confirm 
whether those agents acted synergistically by constructing isobolo-
grams or calculating the combination index (CI) (Junio et al., 2011). 
Therefore, the objective of our work was to evaluate the ability of phe-
nols to act in combination as inhibitory synergists against C. albicans 
virulence switch. For this study, gallic (GA), ferulic (FA), and sinapic 
acid (SA) were selected as they are present in a wide variety of plant 
sources or are abundant in coproducts of agricultural based processes 
making them readily accessible for further isolation (Gallucci et al., 
2014), and also showed the most potent effects (IC > 50 > 50) when 
used in isolation compared with several other phenolic acids and fla-
vonoids when tested at various concentrations. 
As modulation of histone H3 lysine 56 acetylation (H3K56ac) has 
shown to affect morphogenesis of C. albicans cells (Kaplan et al., 
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2008), the response of H3K56 acetylation (ac) was also monitored to 
determine a possible mechanistic target in response to the final syn-
ergistically active phenol cocktail. 
2   Materials and methods 
2.1   Yeast-to-hyphae transition assay 
Culture stocks of C. albicans strain SC5314 (ATCC 2430) were prepared 
as described by Hornby et al. (2001). The cells were stored at 4°C in 50 
mM potassium phosphate buffer (pH 6.5) until use. Yeast cells from 
the stock cultures were induced to the hyphae form by inoculating 1.5 
× 107 cells per milliliter into 125 ml Erlenmeyer shake flasks contain-
ing 25 ml of N-acetylglucosamine (GlcNAc) differentiation medium 
(DM2.8 ml of 0.1 M imidazole buffer, 0.75 ml of 0.1 M MgSO4, 0.65 ml 
of 0.1 M GlcNAc, and 20.8 ml of nanopure water), pH ~6.5 (Hornby et 
al., 2001). Flasks were incubated at 37°C for 24 hr with constant aer-
ation and agitation (250 rpm). Samples were collected at 0, 3, 6, and 
24 hr of incubation for microscopic examination and histone extrac-
tion. Images of the cells were obtained by using an Olympus FV500 
confocal laser scanning microscope (CLSM) with an Olympus IX81 in-
verted microscope with the UPlan SApo 60X/1.35 oil lens (Figure 1). 
2.2   Yeast-to-hyphae inhibition assay 
Caffeic acid was purchased from MP Biomedicals (Aurora, OH) and 
quercetin from Alfa Aesar (Ward Hill, MA). All the other phenolic com-
pounds (kaempferol, catechin, chlorogenic, and GA, FA, and SA) were 
obtained from Sigma-Aldrich (St. Louis, MO). Each phenol was pre-
pared fresh in 0.0–2.2% dimethyl sulfoxide (DMSO) (v/v) to aid in sol-
ubility. DSMO levels did not exceed 2.2%, because preliminary studies 
showed that higher levels contributed to hyphae inhibition. A given 
phenol was added at 2–5 different concentrations to DM. The highest 
phenol level used was based on its solubility capacity in 2.2% DMSO. 
Cells from a fresh yeast stock were inoculated into the phenolic sup-
plemented DM at 1.5 × 107 cells per milliliter and incubated at 37°C 
for 24 hr with constant aeration and agitation (250 rpm). Medium con-
taining only GlcNAc + DMSO served as the positive control. Aliquots 
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of the media (100 μl) were collected at 0, 3, 6, and 24 hr of incuba-
tion, and the cells were counted with a hemocytometer. Considering 
that DM does not allow cell proliferation, the number of hyphae cells 
was determined by subtracting the number of yeast cells at each time 
point (YC) from the number of initial cells (IYC) (at 0 hr). Percent of hy-
phae inhibition was calculated using the formula: (YC-YCc) /IYC) *100, 
where YCc = number of untransformed yeast cells in the positive con-
trols at the corresponding sampling times point. Phenols that did not 
pass the screening process (percent inhibition greater than 25%) were 
eliminated from further evaluation. For the phenols tested, GA, FA, and 
SA acids were able to inhibit C. albicans at IC25, a range of concentra-
tions was selected for developing dose response curves (percent in-
hibition vs concentration millimolar) based upon their degree of effi-
cacy determined from the screening trials. The two compounds that 
resulted in the highest percent inhibition after 24 hr (GA and FA) were 
then combined. A base compound was then selected as the most effi-
cacious agent, in this case FA. Thus, each of four FA solutions (1, 2, 3, 
and 4 mM) were combined with each of three GA concentrations (2.5, 
7.5, and 10 mM). The GA:FA combinations were monitored for their 
ability to prevent hyphal formation as described for the isolated com-
ponents (Figure 3). After the two compound experiments were com-
pleted, phenols achieving minimally percent inhibition of 25% after 24 
hr were combined with GA and FA, which in this case was only SA. Five 
concentrations of FA and SA at 1:1 ratio (1, 2, 3, 4, and 5 mM) were 
combined with three concentrations of GA (2.5, 7.5, and 25 mM). (For 
clarification, X millimolar FA:SA means that  each phenolic acid was 
present at a final concentration of X millimolar). Cells were inoculated 
at 1.5 × 107 cells per milliliter into the DM cocktail supplemented DM, 
analyzed as described above and were also used for histone extraction 
(untreated and the 24 hr phenolics treated samples). Two–three rep-
licates were completed for all the inhibition experiments and dose–
response curves were constructed from these results. 
2.3   Histone extraction and immunoblotting 
Histones were extracted immediately after finishing the inhibition 
studies as described by (Hasim, Tati, Madayiputhiya, Nandakumar, & 
Nickerson, 2013). This procedure consisted of centrifuging the cells at 
4–10°C until a pellet was formed and clear supernatant was apparent. 
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After the pellets were washed twice in ice cold water, ~ 0.5 g of the 
pellet was resuspended in 1 ml of spheroplasting buffer, which con-
sisted of 1 M sorbitol, 25 mM Tri-HCL, (pH 7.0) 100 mM dithiothrei-
tol, 10 mM phenylmethanesulfonylfluoride, 25 mM EDTA, and 0.01% 
(v/v) β-mercaptoethanol for 30 min at room temperature. The cells 
were then centrifuged again until the cell debris had pelleted that 
also contained a clear supernatant. The pellet was then subjected an 
addition time to 1 ml of the spheroplasting buffer, but that also con-
tained yeast cell-wall degrading enzymes (3.5 mg zymolyse) for 3–4 
hr with gentle shaking at 30°C. The suspension was again centrifuged 
at 4–10°C until a pellet that now contained only the spheroplasts. The 
spheroplasts were submerged in in 1 ml of histone extraction buffer 
(0.25 M sucrose, 60 mM KCl, 3 mM MgCl2, 15 mM Pipes pH 6.8, 0.8% 
Triton X-100, and protease inhibitor cocktail), overnight at 4°C with 
gentle rocking. The tubes were centrifuged at 9,000 g in a microfuge 
at 4°C for 20 min, whereupon the pellets were resuspended in 1 ml 
of 0.4 M H2SO4, and centrifuged at 13,000 g for 5 min. The super-
natants were transferred to a new tube, and 12 volumes of cold. Ac-
etone were added to precipitate the proteins overnight at 20°C. The 
tubes were then centrifuged at 6,000 g for 15 min, the pellets resus-
pended in 100 ml of 4 M urea. 
Protein concentrations were determined using the Bradford assay 
(Bradford, 1976). Extracts of 20 μl were separated on 17% Tris- Glycine 
polyacrylamide gels, transferred onto polyvinylidene fluoride mem-
branes and probed with rabbit anti-H3K56ac (1:2,000; Abcam) or rab-
bit anti-H3 (1:1,000; Abcam; da, Boyartchuk, Zhu, & Kaufman, 2010). 
Antibody binding was detected using goat anti-Rabbit IgG conju-
gated to horseradish peroxidase (HRP; 1:20,000, Abcam) and was vi-
sualized by 3,3′-diaminobenzidine tetrahydrochloride (DAB) substrate 
(Thermo Scientific Pierce, Rockford, IL) until the desired staining in-
tensity was obtained  
2.4   Statistical and synergism analysis 
A factorial design was applied to the individual compound inhibi-
tion experiments with replication, time, and compound as factors. 
After confirmation of insignificant replication effect, replicate data 
were pooled and the new factorial analyses included time and chem-
ical using Fisher’s least significant difference (LSD) at a significance 
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level of p < 0.05. Analysis of the combined compound experiments 
was completed similar to the isolated compounds, except that con-
centrations of each compound was used as a factor in the model. 
Treatment groupings for all data points were calculated using Fisher’s 
LSD. Statistical Analysis System 9.3 was used to perform these anal-
yses. One-way analysis of variance was calculated to compare differ-
ent groups of Figure 5 using a Bonferroni post-hoc analysis. A signif-
icance level of p < 0.05 was assumed for those statistical evaluations, 
which were computed with GraphPad Software. The combined phe-
nols acting as synergists were analyzed by constructing isobolograms 
as previously described (Junio et al., 2011; Li, Wu, Wu, et al., 2014). 
Treatment concentrations that resulted in 50% inhibition of yeast-to-
hyphae (IC50) after 24 hr were plotted on isobolograms. The IC50 for 
each set of compounds was obtained by regression analysis fitted to 
the dose response curves (Figure 3 and 4). Synergism was substanti-
ated by determining the (CI) calculated as follows: CI = (c1/Cx1) + (c2/
Cx2), where Cx1 is the concentration of compound 1 required to in-
hibit 50% of hyphal form alone, and c1 is the concentration of com-
pound 1 required to produce the same effect in combination with c2. 
Similarly, Cx2 is the concentration of compound 2 required to inhibit 
50% of hyphal form alone, and c2 is the concentration of compound 
2 required to produce the same effect in combination with c1. The CI 
values were defined as follows: less than 1, synergism; 1, additive; and 
greater than 1, antagonism effect (Li et al., 2014). 
3   Results and discussion 
3.1   Effects of isolated components on C. albicans yeast-to-hy-
phae transition 
In this manuscript, isolated phenols were initially screened as potential 
inhibitors “to” the yeast-to-hyphae transition of C. albicans. Different 
concentrations of each phenol were added to the DM followed by in-
oculation of stationary yeast cells. Hyphae inhibition by each phenol 
at each of 4–5 concentrations was determined at four time points (0, 
3, 6, and 24 hr). These time points were selected because cells at 0 hr 
showed a typical yeast form, round to ovoid in shape and separated 
from each other (Figure 1). At 3 hr, greater than 95% of the cells were 
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in the germ tube form, as expected, and partially grouped in small to 
medium clumps. Longer and wider filaments were apparent at 6 hr 
compared with 3 hr, and the cells were mostly grouped in medium 
clumps. At 24 hr, all cells formed larger clumps and had transitioned 
mostly to hyphae (Figure 1). Another related study examined the ef-
fects of a flavonoid rich honey extract on the C. albicans phenotypic 
switch using similar incubation time (6 and 18 hr) used herein (Cano-
nico et al., 2014). 
Among the phenols tested for this experiment, kaempferol, caffeic 
acid, chlorogenic acid, quercetin, and catechin alone were not able 
to inhibit greater than 25% hyphae using concentrations soluble in 
the delivery system. These results do not support other published ac-
counts where phenols were used for similar purposes, most notably, 
Figure 1. Morphology of Candida albicans cells during 24 hr of yeast-to-hyphae 
transition induction. (a) 0 hr, control group, (b) 3 hr, (c) 6 hr, and (d) 24 hr after in-
cubation. Cells from 0 hr time point were inoculated into N-acetylglucosamine 
(GlcNAc) DM in order to induce germ tube formation. Scale bars represent 20 μm. 
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a catechin. Saito et al. (2013) showed that hyphae formation by C. al-
bicans (NUD-202) was nearly inhibited at 2.8 mM catechin using 10% 
fetal calf serum (FCS) as the inducing agent. For this study, 95% of C. 
albicans transitioned to hyphae within 3 hr with 3.5 mM catechin but 
GlcNAc was the inducer (data not shown). These experiments may dif-
fer due the use of different C. albicans strains and the inducing DM. 
Mosel, Dumitru, Hornby, Atkin, and Nickerson (2005) showed that 
different concentrations of farnesol (1–250 μM) were able to reduce 
germ tube formation to 50% after 4 hr when different inducing con-
ditions and strains (SC5314 and A72) were used. Resveratrol (200–900 
μM) impaired the yeast-to-hyphae transition of C. albicans (SC5314) 
differently in terms of percent inhibition (treatment time of 60–300 
min) and hyphal outgrowth under serum, pH, and nutrient-induced 
conditions (Kazuko et al., 2010). The mode of action of an antican-
didal in response to different DM or strains is most likely due to the 
flexibility of C. albicans to metabolize available nutrients in its various 
habitats within the host, and thereby, is able to activate a variety of 
signals specific to that niche (Brown & Gow, 1999). 
The inducing agent used in this study is an amino-sugar present 
in a number of eukaryotic cells, especially mucosal cells. As such, C. 
albicans encounters GlcNAc in many of its habitats resulting in the 
regulation of its genes involved in metabolism, morphogenesis, and 
virulence (Huang et al., 2010; Singh, Ghosh, & Datta, 2001). GlcNAc 
activates C. albicans transition by regulating amino acid synthesis into 
a nitrogen limited condition (Brown & Gow, 1999). Another study 
showed that at low ambient pH, GlcNAc induced the hyphal cAMP de-
pendent cascade pathway that caused filamentation using a mutant 
lacking genes to metabolize GlcNac (Singh et al., 2001). As evidenced 
by these seminal studies, GlcNAc has extensive regulatory control over 
C. albicans, thereby requiring higher levels of phenols to inhibit the 
switch. Studies are in progress to ascertain if lower phenols levels will 
be more effective with different inducing DM and C. albicans strains. 
The most efficacious compound on hyphae inhibition was FA fol-
lowed by GA (Figure 2) among the individual phenols tested. For GA, 
the percent inhibition increased in a dose-dependent manner at 3 and 
24 hr (Figure 2a). Interesting, only the highest GA concentration (80 
mM) was able to significantly inhibit hyphae formation after 6 hr of 
treatment compared with the control (p < 0.05). Yet, the two highest 
concentrations (70 and 80 mM) induced the most effective inhibition 
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at a treatment duration of 3 hr indicating that the GA activity reduces 
with time. The response of the 6 hr treated sample was not signifi-
cantly different from that of the 24 hr sample (p > 0.05) with the ex-
ception of the highest level (80 mM). At this concentration, the 24 hr 
treatment percent inhibition was higher than at 6 hr. Considering that 
more yeast cells were present after 24 hr of treatment compared with 
6 hr, C. albicans hyphae may have remediated back to its yeast form 
as no proliferation occurs with this differentiation media, as stated 
previously, which was further  supported by the lack of visual yeast 
buds as would be expected if proliferation was indeed occurring. To 
our knowledge, studies have not been reported on the GA suppres-
sion of the hyphae transition, but rather cell growth inhibition (Alves 
et al., 2014). Still, to ensure that the phenol was not a nutrient source 
for cell growth in this study, an experiment was conducted exposing 
yeast cells inoculated into the GlcNAc supplemented with the highest 
levels of phenols selected for this study. The results supported the pre-
viously cited study and showed that the number of yeast cells did not 
change significantly by 24 hr when exposed to GA (data not shown). 
FA significantly prevented hyphae formation in a concentration-
dependent manner (Figure 2b) with 9 mM producing a percent inhi-
bition of 93.2 ± 7.1%, 91.6 ± 10.2%, and 90.9 ± 6.9% at 3, 6, and 24 
hr of treatment, respectively. At 7 and 8 mM, the percent inhibition 
of FA (24 hr) was significantly lower compared with 3 and 6 hr (Figure 
2b) but was not different between any of the time points at 9 mM. 
Figure 2. Effects of (a) gallic acid (GA) and (b) ferulic acid (FA) on hyphae inhibition 
at 3, 6, and 24 hr of treatment. SC5314 C. albicans cells were treated with GA or FA 
at different concentrations. Each point and vertical bar represents the mean ± stan-
dard deviation of three replicates.  
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FA was the most efficacious anticandidal as the IC50 at 24 hr was 8.0 
± 0.09 mM compared with 83.9 ± 5.32 mM obtained by GA (data not 
shown). The activity of FA against multiple types of fungi have been 
well documented (Guzman, 2014). Yet, only a few studies have re-
ported on this abundant cinnamic acid ability to protect against C. 
albicans, and those studies only targeted growth suppression. In one 
study, a minimum inhibitory concentration (MIC) value of 659 μM 
FA (Ergün, Çoban, Onurdag, & Banoglu, 2011) prevented C. albicans 
growth, whereas another report showed a MIC value greater than 10 
mM (Nakauchi, Ikemoto, Yamanishi, & Ozaki, 2002). This difference in 
the inhibitory concentrations of the active molecule could be due to 
the different strains or media used. 
3.2   Effects of two phenols on C. albicans yeast-to-hyphae 
transition 
Two–three phenolics were then analyzed as potential synergistic in-
hibitors that specifically targets the C. albicans yeast-to-hyphae transi-
tion. Although the 3 and 6 hr treatment periods were evaluated (data 
not shown), the effect of the combined phenols over 24 hr was the 
primary focus of this study due to the community morphology during 
this time period. FA served as the base compound considering it was 
the most efficacious phenolic agent. Therefore, FA (1, 2, 3, and 4 mM) 
were each combined with GA at 5, 7.5, and 10 mM and then studied 
for their ability to suppress the hyphae form. These concentrations 
were selected as they did not show any or only minimal protection as 
isolated components (Figure 2a,b). When treated with 4 mM FA, hy-
phae was readily apparent (Figure 3a). However, addition of GA at 5, 
7.5, and 10 mM to 4 mM FA significantly inhibited hyphae resulting 
in 40.2 ± 10.5, 75.7 ± 9.9, and 75.3 ± 10.3% suppression, respectively 
(Figure 3a). Although the IC50 for FA was 8.0 ± 0.09 mM and GA was 
83.9 ± 5.32 mM at 24 hr, a 1.9-fold, 2.3-fold, and 2.6-fold reduction 
in the IC50 of FA occurred when combined with 5 mM, 7.5 mM, and 10 
mM GA, respectively (Figure 3b). 
Isobolograms were configured to evaluate the interaction be-
tween FA and GA. As confirmed by the concave dashed line (Figure 
3b) generated by plotting the IC50 for the phenols at each concen-
tration tested, the compounds acted synergistically to inhibit hy-
phae formation. Additionally, the CI was less than 1; CI = 0.6 for 5 
Câmara  et  al .  in  Phytotherapy  Research  33  (2019 )       12
mM GA + 4.3 mM FA; and CI = 0.5 for combinations of 7.5 mM GA 
+ 3.4 mM FA and 10 mM GA + 3.0 mM FA (Figure 3b). The dramatic 
decrease in the IC50 of GA (83.9 ± 5.32 mM) and FA (8.0 ± 0.09 mM) 
further confirm that these two compounds act as synergist inhibi-
tors of the C. albicans switch. 
3.3   Effects of three phenols on C. albicans yeast-to-hyphae 
transition 
SA was added to the GlcNAc DM to determine whether a third com-
pound could affect the IC50 of GA and FA to produce a more potent 
synergistic effect. For these experiments, the same levels of FA:SA 
were used to simplify the isobolograms construction, whereas GA was 
added at 2.5, 7.5, and 25 mM. (The range of GA concentrations was 
increased to obtain a wider distribution of the points for the isobolo-
gram). Flasks containing only FA:SA at all concentrations tested and 
only GA at three fixed concentrations served as controls. 
A significant improvement in protection occurred only after GA was 
added to the FA:SA combination. In the presence of 3 mM FA: SA, hy-
phae was not inhibited (Figure 4a), but when GA was added at 2.5, 
Figure 3. (a) Combined effects of gallic acid (GA) and FA on hyphae inhibition af-
ter 24 hr treatment and (B) isobologram analysis. SC5314 Candida albicans cells 
were treated with GA combined with FA at different concentrations. According to 
the IC50 determination, when GA (5, 7.5, and 10 mM) was combined with FA (4.3, 
3.4, and 3 mM, respectively), the combination index (CI) of each combination was 
less than 1. Each point and vertical bar represents the mean ± standard deviation 
of three replicates.
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7.5, and 25 mM, inhibition increased to 11.8 ± 5.82, 67.2 ± 5.28, and 
87.8 ± 6.22%, respectively. The isobologram showed that GA inter-
acted synergistically with FA:SA as indicated by the concave line (Fig-
ure 4b) and confirmed by CI for each data points, which was less than 
1; CI = 0.9 for combination of 2.5 mM GA + 4.1 mM FA:SA; and CI = 
0.6 for combination of 7.5 mM GA + 2.4 mM FA:SA and 25 mM GA + 
1.4 mM FA:SA. SA has been studied for its antimicrobial activity, but 
reports on its antifungal effect remain limited (Guzman, 2014). None-
theless, the results show that this compound may be of interest for 
targeting a virulence factor or C. albicans research as the final IC50 was 
7.5 mM GA + 2.4 mM FA:SA. 
During the course of this study, we recognized that pH may have 
affected percent inhibition value considering the wide concentration 
range of acidic compounds used. A study was thus conducted, where 
pH was adjusted in the DM to 4.5, 4.4, and 3.1, which simulated the 
conditions produced by 9 mM FA, 5 mM FA:SA, and 80 mM GA, re-
spectively. The yeast-to-hyphae transition was not inhibited by the 
lower pH indicating that the protective responses were due to other 
properties exerted by the phenolic compounds. 
Figure 4. (a) Combined effects of gallic acid (GA), ferulic acid (FA), and sinapic acid 
(SA) on hyphae inhibition after 24 hr treatment and (b) isobologram analysis. SC5314 
Candida albicans cells were treated with GA combined with FA and SA at different 
concentrations. According to the IC50 determination, when GA (2.5, 7.5, and 25 mM) 
was combined with FA:SA (4.1, 2.4, and 1.4 mM, respectively), the CI of each com-
bination was less than 1. Each point and vertical bar represents the mean ± stan-
dard deviation of three replicates.
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3.4   H3K56 acetylation in phenolic treated and nontreated  
C. albicans cells 
Genetic studies have been conducted on C. albicans, revealing poten-
tial new targets for antifungal therapy (Becker et al., 2010; da et al., 
2010; Mishra, Baum, & Carbon, 2011; Wurtele et al., 2010). In particu-
lar, Wurtele et al. (2010) detected that preserving the expression of the 
enzyme HST3 (histone deacetylase that removes H3K56ac genome-
wide) reduced H3K56ac compared with cells with lower expression of 
this enzyme, resulting in cells with the hyphae phenotype. da et al. 
(2010) reported that H3K56ac was lost in mutants lacking the histone 
acetyltransferase responsible for H3K56ac (Rtt109) and a large pro-
portion of cells were filamentous compared with wild-type yeast cells. 
Moreover, elevated expression was detected in the hyphal-induced 
gene (orf19.7531) located in the mutant cells (rtt109−/−). Both studies 
used the same C. albicans strain used in the present work. Due to as-
sociation between H3K56ac and morphogenesis of C. albicans, par-
ticularly the total absence of acetylation originating filamentation, we 
hypothesized that H3K56ac may play an important role in the yeast-
to-hyphae transition. An experiment was therefore completed on C. 
albicans acetylation throughout its transition period, which is the first 
reported to our knowledge. We further monitored the H3K56ac pro-
file of phenolic treated vs. its nontreated counterpart to determine if 
a correlation existed between acetylation and yeast to hyphae transi-
tion in response to a phenol treatment, thus being a possible target. 
Histones were extracted at 0, 3, 6, and 24 hr from nontreated cells 
and from the 24 hr treated cells using 7.5 mM GA + 2.4 mM FA:SA 
treatment. This treatment was used because the lowest concentra-
tions of all three phenols were used among the three IC50’s shown 
in Figure 4b. Immunoblot analysis of the protein extract detected 
H3K56ac in all samples (Figure 5a). Using densitometry, the gel was 
quantified (Figure 5b) by the relative density of each H3K56ac sam-
ple normalized to the H3 (loading control). H3K56ac was significantly 
higher in yeast cells (0 hr) compared with hyphae cells at 3, 6, and 
24 h, although acetylation of samples was not significantly different 
between these three time points. These results suggest that C. albi-
cans cells’ histone H3 protein was deacetylated when induced to hy-
phae. Interestingly, the deacetylation results were significantly similar 
whether the cells were in a free germ form state (3 hr) or as clumping 
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growing hyphae (6 and 24 hr) indicating that deacetylation is involved 
throughout the transition or is an initiator that does not change once 
the process begins. Nonetheless, cells treated with GA + FA:SA levels 
required to inhibit 50% of hyphal growth resulted in H3K56ac profile 
similar to yeast cells (p > 0.05). The phenols may, in part, prevent his-
tone H3 deacetylation, maintaining the yeast H3K56ac profile, which 
may be responsible for lower expression of a hyphae-induced gene 
(da Rosa et al., 2010). 
Figure 5. (a) Immunoblot of H3K56ac and total H3 in histone extracts from SC5314 
strain during yeast-to-hyphae transition induced by N-acetylglucosamine differ-
entiation media at 37°C. Non-treated samples (0–24 h) were incubated in flasks 
containing only differentiation media, whereas treated samples (24 hr-IC) were in-
cubated in differentiation media supplemented with 7.5 mM GA + 2.4 mM FA:SA 
(IC50). Cells incubated for 24 hr in the presence of DMSO (24 hr-D) were used as 
positive control for treated samples. (b) Data from immunoblot were quantified by 
densitometry and H3K56ac was normalized by H3 densitometry. * p < 0.05 vs. 0 hr, 
# p < 0.05 vs. 24 hr-IC50.
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4   Conclusion 
Phenols (GA and FA) tested in isolation exerted their activity against 
C. albicans yeast-to-hyphae transition at higher levels of the concen-
trations tested. When combined, however, both GA and FA levels de-
creased dramatically to achieve this antivirulence effect with even fur-
ther reduction in concentration upon addition of SA. Importantly, the 
hyphal inhibitor effect of the GA-FA combination correlated to the 
maintenance of a histone H3 acetylation. Considering the conditions 
of incubation used (aerobic and deprivation of nutrients) and the high 
phenolic concentration needed for these studies, oral or topical treat-
ments may be the more practical applications for this treatment ap-
proach. Nonetheless, this study is the first to substantiate that phenols 
are capable of acting as synergists to prevent C. albicans yeast-to-hy-
phae transition. 
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